{"nctId":"NCT00420992","briefTitle":"A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee","startDateStruct":{"date":"2006-12"},"conditions":["Osteoarthritis","Chronic Pain"],"count":547,"armGroups":[{"label":"ALO-01","type":"EXPERIMENTAL","interventionNames":["Drug: ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)","otherNames":["Embeda"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject is 21 years of age or older\n* Subject is either not of childbearing potential OR subject must use an acceptable method of birth control if of childbearing potential\n* Negative pregnancy test if female of childbearing potential\n* Subject is in general good health\n* Subject required treatment of joint pain within the last 90 days\n* Subject has primary diagnosis of osteoarthritis (OA) of the hip or knee\n\nExclusion Criteria:\n\n* Subject has a documented history of allergic reaction or intolerance to morphine or other opioids\n* Subject is pregnant or breast-feeding\n* Subject is receiving systemic chemotherapy\n* Subject has a history of drug abuse/dependence/misuse or alcohol abuse/dependence\n* Subject has history of major depressive disorder not controlled with medication\n* Subject has any chronic pain syndrome (i.e., fibromyalgia) that may interfere with the symptoms of OA\n* Subject has active gastrointestinal disease, with the exception of gastroesophageal reflux disease (GERD)\n* Subject has a documented history of rheumatoid arthritis, uncontrolled inflammatory arthritis or non-steroidal anti-inflammatory drug (NSAID)-dependent inflammatory arthritis","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Randomization to 12 Weeks Following Randomization in Diary Brief Pain Inventory Score of Average Pain (Daily Scores of Average Pain Averaged Over 7 Days)","description":"Change in pain intensity scale. Average pain intensity over last 24 hours rated daily from 0=no pain to 10=worst pain.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":"1.94"},{"groupId":"OG001","value":"0.3","spread":"2.05"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":171},"commonTop":["Constipation","Nausea","Somnolence","Vomiting","Diarrhoea"]}}}